Condition

Extrapulmonary Small Cell Carcinoma

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions4

Lead sponsors shown2

Clinical trials

2 shown

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory DiseaseNCT07509034 · 2026-10-12

RECRUITING

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLCNCT04010357 · 2020-01-13

COMPLETED

Common interventions

Abemaciclib,DRUG1Autologous B7-H3 CAR TDRUG1CyclophosphamideDRUG1FludarabineDRUG1

Leading sponsors

Case Comprehensive Cancer Center1National Cancer Institute (NCI)1

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.